GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation

NASDAQ:GEHC • US36266G1076

70.49 USD
+0.16 (+0.23%)
Last: Mar 13, 2026, 11:25 AM

This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

GEHC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. GEHC scores excellent on profitability, but there are concerns on its financial health. GEHC is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

7

1. GEHC Profitability Analysis

1.1 Basic Checks

  • In the past year GEHC was profitable.
  • In the past year GEHC had a positive cash flow from operations.
  • Each year in the past 5 years GEHC has been profitable.
  • GEHC had a positive operating cash flow in each of the past 5 years.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 5.65%, GEHC belongs to the best of the industry, outperforming 81.52% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 20.09%, GEHC belongs to the top of the industry, outperforming 94.57% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 7.81%, GEHC belongs to the best of the industry, outperforming 82.07% of the companies in the same industry.
  • GEHC had an Average Return On Invested Capital over the past 3 years of 8.25%. This is in line with the industry average of 9.18%.
Industry RankSector Rank
ROA 5.65%
ROE 20.09%
ROIC 7.81%
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • The Profit Margin of GEHC (10.11%) is better than 83.15% of its industry peers.
  • GEHC's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 13.40%, GEHC belongs to the best of the industry, outperforming 80.43% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GEHC has declined.
  • GEHC has a worse Gross Margin (39.98%) than 67.39% of its industry peers.
  • GEHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.4%
PM (TTM) 10.11%
GM 39.98%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

3

2. GEHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GEHC is destroying value.
  • Compared to 1 year ago, GEHC has less shares outstanding
  • GEHC has more shares outstanding than it did 5 years ago.
  • GEHC has about the same debt/assets ratio as last year.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.84 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • GEHC has a Altman-Z score (1.84) which is comparable to the rest of the industry.
  • GEHC has a debt to FCF ratio of 6.67. This is a slightly negative value and a sign of low solvency as GEHC would need 6.67 years to pay back of all of its debts.
  • GEHC's Debt to FCF ratio of 6.67 is fine compared to the rest of the industry. GEHC outperforms 75.54% of its industry peers.
  • GEHC has a Debt/Equity ratio of 0.92. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
  • The Debt to Equity ratio of GEHC (0.92) is worse than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.67
Altman-Z 1.84
ROIC/WACC0.8
WACC9.75%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.37 indicates that GEHC should not have too much problems paying its short term obligations.
  • GEHC's Current ratio of 1.37 is on the low side compared to the rest of the industry. GEHC is outperformed by 78.26% of its industry peers.
  • GEHC has a Quick Ratio of 1.13. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of GEHC (1.13) is worse than 73.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.13
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

4

3. GEHC Growth Analysis

3.1 Past

  • GEHC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.00%.
  • The earnings per share for GEHC have been decreasing by -31.63% on average. This is quite bad
  • GEHC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.85%.
  • The Revenue has been growing slightly by 3.74% on average over the past years.
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.20% on average over the next years. This is quite good.
  • GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

7

4. GEHC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.39, which indicates a correct valuation of GEHC.
  • Compared to the rest of the industry, the Price/Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 85.33% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of GEHC to the average of the S&P500 Index (25.71), we can say GEHC is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 13.64, which indicates a correct valuation of GEHC.
  • Based on the Price/Forward Earnings ratio, GEHC is valued cheaper than 88.59% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.82. GEHC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.39
Fwd PE 13.64
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaper than 88.59% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, GEHC is valued cheaper than 86.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.35
EV/EBITDA 11.26
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)1.2
PEG (5Y)N/A
EPS Next 2Y11.37%
EPS Next 3Y11.08%

3

5. GEHC Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.18%, GEHC is not a good candidate for dividend investing.
  • GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.21. GEHC pays more dividend than 89.67% of the companies in the same industry.
  • With a Dividend Yield of 0.18, GEHC pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • GEHC pays out 3.07% of its income as dividend. This is a sustainable payout ratio.
DP3.07%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

GEHC Fundamentals: All Metrics, Ratios and Statistics

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (3/13/2026, 11:25:10 AM)

70.49

+0.16 (+0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners93.29%
Inst Owner Change12.34%
Ins Owners0.3%
Ins Owner Change0.63%
Market Cap32.13B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target95.29 (35.18%)
Short Float %2.2%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.3%
PT rev (3m)6.38%
EPS NQ rev (1m)6.22%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)2.9%
EPS NY rev (3m)3.15%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)1.1%
Revenue NY rev (3m)1.14%
Valuation
Industry RankSector Rank
PE 15.39
Fwd PE 13.64
P/S 1.56
P/FCF 21.35
P/OCF 16.17
P/B 3.1
P/tB N/A
EV/EBITDA 11.26
EPS(TTM)4.58
EY6.5%
EPS(NY)5.17
Fwd EY7.33%
FCF(TTM)3.3
FCFY4.68%
OCF(TTM)4.36
OCFY6.19%
SpS45.26
BVpS22.77
TBVpS-9.3
PEG (NY)1.2
PEG (5Y)N/A
Graham Number48.44
Profitability
Industry RankSector Rank
ROA 5.65%
ROE 20.09%
ROCE 9.94%
ROIC 7.81%
ROICexc 9.32%
ROICexgc 25%
OM 13.4%
PM (TTM) 10.11%
GM 39.98%
FCFM 7.3%
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.67
Debt/EBITDA 2.85
Cap/Depr 83.39%
Cap/Sales 2.34%
Interest Coverage 5.29
Cash Conversion 59.47%
Profit Quality 72.18%
Current Ratio 1.37
Quick Ratio 1.13
Altman-Z 1.84
F-Score4
WACC9.75%
ROIC/WACC0.8
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.3%
EBIT Next 3Y14.92%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%

GE HEALTHCARE TECHNOLOGY / GEHC FAQ

What is the fundamental rating for GEHC stock?

ChartMill assigns a fundamental rating of 5 / 10 to GEHC.


What is the valuation status for GEHC stock?

ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.


How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?

GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.


What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?

The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.


Can you provide the dividend sustainability for GEHC stock?

The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 3.07%.